The global native bacterial and viral antigens market is driven by factors such as increasing use of native microbial antigens in diagnostics and therapeutics, and rising prevalence of infectious diseases. However, the limitations associated with native antigens such as high cost, low antigen production levels, and scale-up difficultieshinder the market growth.However, emerging markets are creating growth opportunities for the market players. Antigens are the biomolecules that are capable of triggering immune response in host body through the activation of lymphocytes. Bacterial antigens are used in the development of various types of antibodies in research laboratories for the improvement of immune systems. Moreover, bacterial antigens are also widely used in immunodiagnostic assays such as ELISA. Get sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00014757/?utm_source=FreePlatform&utm_medium=10389